Infinity Pharmaceuticals, Inc.
CIK 1113148 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Infinity Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 20, 2023 | 25-NSE | 0001354457-23-000865 |
| Sep 29, 2023 | 8-K | 0001113148-23-000018 |
| Sep 13, 2023 | 8-K | 0001113148-23-000016 |
| Sep 12, 2023 | 4 | 0000899243-23-018762 |
| Sep 11, 2023 | 8-K | 0001113148-23-000014 |
| Sep 1, 2023 | 8-K | 0001113148-23-000012 |
| Aug 10, 2023 | 10-Q | 0001113148-23-000009 |
| Jul 25, 2023 | 8-K | 0001140361-23-036062 |
| Jul 24, 2023 | 8-K | 0001140361-23-035755 |
| Jul 14, 2023 | 8-K | 0001140361-23-034615 |
| Jul 10, 2023 | DEFA14A | 0001140361-23-033842 |
| Jul 5, 2023 | DEFA14A | 0001140361-23-032922 |
| Jul 3, 2023 | 425 | 0001140361-23-032816 |
| Jul 3, 2023 | DEFA14A | 0001140361-23-032628 |
| Jul 3, 2023 | 8-K | 0001140361-23-032815 |
| Jun 30, 2023 | 8-K | 0001140361-23-032462 |
| Jun 29, 2023 | DEFA14A | 0001140361-23-032016 |
| Jun 27, 2023 | DEFA14A | 0001140361-23-031606 |
| Jun 21, 2023 | DEFA14A | 0001140361-23-030637 |
| Jun 20, 2023 | 425 | 0001140361-23-030389 |
| Jun 20, 2023 | 8-K | 0001140361-23-030387 |
| Jun 20, 2023 | DEFA14A | 0001140361-23-030395 |
| Jun 16, 2023 | DEFA14A | 0001140361-23-030215 |
| Jun 16, 2023 | DEFA14A | 0001140361-23-030193 |
| Jun 6, 2023 | DEFA14A | 0001140361-23-028563 |